Publication | Closed Access

A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin®) in Healthy Male Subjects

Pharmacological StudyMedicineClinical TrialsTherapeutic EfficacyGlobal PhaseAntiviral TherapyPharmacotherapyHealthy Male SubjectsBiosimilar Bat1706Antiviral DrugPharmacology